Hormonal Therapy with Letrozole for Relapsed Epithelial Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|66|2|112-117

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.2, 2004-05, pp. : 112-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormonal therapy for epithelial ovarian cancer

By Markman Maurie  

Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. : 847-851

Future Medicine

Access to resources Recommend Favorite

Radiation Therapy for Chemotherapy-Resistant Recurrent Epithelial Ovarian Cancer

By  

Oncology, Vol. 86, Iss. 4, 2014-05 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Letrozole: advancing hormone therapy in breast cancer

By Lee Rebecca J   Armstrong Anne C   Wardley Andrew M  

Women's Health, Vol. 8, Iss. 6, 2012-11 ,pp. : 611-618

Future Medicine

Access to resources Recommend Favorite

Second-Line Antiandrogen Therapy in Japanese Men with Advanced Prostate Cancer Relapsed after Primary Combined Androgen Blockade: Who Will Benefit from Second-Line Hormonal Therapy?

By  

Urologia Internationalis, Vol. 85, Iss. 4, 2010-08 ,pp. : 491-497

Karger

Access to resources Recommend Favorite

Frontline treatment of epithelial ovarian cancer

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S6, 2015-12 ,pp. : 1-16

John Wiley & Sons Inc

Access to resources Recommend Favorite